Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Feb 10, 2012

Mylan Intends to Challenge Unfavorable Verdict in Patent Trial Related to Mylan's Generic Version of Sunovion's Xopenex® Inhalation Solution

Feb 09, 2012

Testimony of Mylan CEO Heather Bresch Before the U.S. Congress in Support of a Generic Drug User Fee Program

Feb 09, 2012

Mylan CEO Heather Bresch Testifies Before Congress in Support of Generic Drug User Fee Program and Urges Update of Federal Food, Drug and Cosmetic Act of 1938 to Create a Level Playing Field for Manufacturers

Feb 09, 2012

Mylan Receives Final FDA Approval for First Generic Version of Doryx® Tablets, 150 mg

Feb 06, 2012

Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant

Feb 02, 2012

Mylan Receives Tentative FDA Approval for Generic Version of Lipitor®

Jan 24, 2012

Mylan to Host Investor Day on Feb. 21, 2012, in New York City

Jan 19, 2012

Mylan Launches Innovative Version of Antiepileptic Drug Levetiracetam

Jan 09, 2012

Mylan Confirms First-to-File Patent Challenge Relating to Actoplus Met® XR Tablets

Dec 27, 2011

Mylan Launches First Generic Version of Teveten® Tablets

Pagination

First page
Previous page
…
Page 64
Page 65
Page 66
Page 67
Current page 68
Page 69
Page 70
Page 71
Page 72
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2024 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.